Day: July 14, 2021

TORONTO, July 14, 2021 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland”) (TSX: NPI) announces it will release its 2021 second quarter financial results after market close on Wednesday, August 11, 2021. Northland’s management will hold an investor conference call and webcast at 10 a.m. Eastern Time (ET) on Thursday, August 12, 2021, followed by a question and answer period with analysts. Conference call details: Date: Thursday, August 12, 2021 Start Time: 10:00 a.m. ETPhone Number:  Toll free (North America):  (833) 693-0550  Toll free (International):    (661) 407-1589Conference ID:   9358403  The call will also be broadcast live on the internet, in listen-only mode and may be accessed on northlandpower.com. For those unable to attend the live call, an audio recording will be available on Northland’s website...

Dr. Duncan will discuss seclidemstat’s potential in treating FET-rearranged sarcomas HOUSTON, July 14, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that Aundrietta Duncan, Ph.D., Director, Non-Clinical Development at Salarius Pharmaceuticals, has been invited to present during the Epigenetic Therapeutic Targets Summit, which is being held virtually July 14-15, 2021. The conference is widely attended by leaders in the field of epigenetic drug development and will include presentations by some of the world’s top 10 largest pharmaceutical companies. Dr. Duncan’s presentation, entitled, “Targeting FET-Rearranged Sarcomas Through Inhibition of LSD1,”...

Figure 1:Plan view of Selected Drill Holes at CindyFigure 2:Cross Section – CIR-08Figure 3:Cross Section – CIR-09Figure 4:Long Section of Cindy Including Mineral DomainsFigure 5:Extended High Resolution Magnetic Surveys and Mititus TargetVANCOUVER, British Columbia., July 14, 2021 (GLOBE NEWSWIRE) — (TSX: MARI) is pleased to announce that drilling results from the remaining reverse circulation (“RC”) drill holes, completed at the Cindy Target (“Cindy”), have intersected significant copper mineralization, extending the strike length to over 800m. Cindy is located less than 5km to the north of the Marimaca Oxide Deposit (“MOD”) and offers potential to add to the Company’s leachable resource base and extend mine life or increase the scale...

Global innovation and digital investment enable clients to achieve sustainability goals TORONTO, July 14, 2021 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company Colliers (NASDAQ and TSX: CIGI) announced today a global strategic partnership with Measurabl, a widely adopted environmental, social, and governance (ESG) data management solution for commercial real estate. In doing so, Colliers augments its Property Management offering with ESG data management and reporting expertise to help clients better manage, measure, disclose and act on their portfolios. As institutional investors, regulators and tenants prioritize ESG transparency and disclosure, property owners today need to account for a different set of sustainability considerations. Measurabl aggregates accurate and auditable ESG...

VANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) — Rockridge Resources Ltd. (TSX-V: ROCK) (OTCQB: RRRLF) (Frankfurt: RR0) (“Rockridge” or the “Company”) is pleased to announce final results from its recently completed diamond drilling program at its Knife Lake Copper Project located in Saskatchewan, Canada (the “Knife Lake Project” or “Property”). The Company drilled a total of 2,043 metres in twelve drill holes and has now received assays and completed interpretation for all holes. Results for the initial nine holes covering Gilbert North and South and the Knife Lake Deposit can be referenced in the Company’s June 17th, 2021, news release. Rockridge will also be commencing a summer exploration program which is described herein. The Knife Lake Project, consisting of 81 claims totaling 55,471 hectares (137,069 acres),...

– Significant commercial strategy and product launch experience –– ATTACK Phase 3 top-line data readout remains on-track for 2H 2021 – WALTHAM, Mass., July 14, 2021 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today the appointment of Anna Diaz Triola as Chief Commercial Officer, effective July 19th 2021. Ms. Triola will be responsible for global commercial strategy, including U.S. sales and marketing operations. “With the ATTACK Phase 3 registration clinical trial nearing completion, we are now engaged in preparing for commercialization of our first product, ahead of top-line results from sulbactam-durlobactam (SUL-DUR) in patients with confirmed carbapenem-resistant Acinetobacter...